AC Immune S.A.
NASDAQ:ACIU · NASDAQ Global Market
+$0.04 today
Vol 0.21M · Avg 0.32M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+31.15%
Period High
$3.99
Period Low
$1.83
Latest
$2.40
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Alpha Tau Medical Ltd.
NASDAQ:DRTS
$863.06M
Alto Neuroscience, Inc.
NYSE:ANRO
$786.10M
Annexon, Inc.
NASDAQ:ANNX
$593.79M
Contineum Therapeutics, Inc. Class A Common Stock
NASDAQ:CTNM
$441.85M
Amarin Corporation plc
NASDAQ:AMRN
$334.75M
Silence Therapeutics plc
NASDAQ:SLN
$327.10M
Cellectis S.A.
NASDAQ:CLLS
$306.27M
Lyell Immunopharma, Inc.
NASDAQ:LYEL
$292.98M
Aldeyra Therapeutics, Inc.
NASDAQ:ALDX
$116.72M
Mereo BioPharma Group plc
NASDAQ:MREO
$50.38M
What is the latest ACIU filing?
The latest filing shown is 4 dated Jun 15, 2026.
How many recent filings does ACIU have?
Intrinsic Alpha currently shows 20 recent filings for ACIU.
Explore More
Continue the stock analysis
Jump to another research area for this company.